Odyssey Health (ODYY) Cash & Current Investments (2014 - 2026)
Odyssey Health's (ODYY) quarterly Cash & Current Investments came in at $297806.0 in Q2 2026, up 9247.33% year-on-year from $3186.0 in Q2 2025, and down 51.68% quarter-over-quarter from $616327.0 in Q1 2026.
Odyssey Health (ODYY) Cash & Current Investments (2014 - 2026) Analysis & Trends
Odyssey Health's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $297806.0 for Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 9247.33% year-over-year to $297806.0 in Q2 2026; TTM through Apr 2026 was $297806.0, a 9247.33% increase from a year earlier, with the FY2025 full-year figure at $19084.0, up 702.19% from the prior year.
- Cash & Current Investments retreated to $297806.0 in Q2 2026 per ODYY's latest filing, from $616327.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $616327.0 in Q1 2026 and bottomed at $1234.0 in Q2 2023.
- The 5-year median for Cash & Current Investments is $52182.0 (2022), against an average of $113889.8.
- Across the five-year window, Cash & Current Investments tumbled 99.54% in 2023 and surged 9247.33% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $50499.0 in 2022, then surged by 291.85% to $197882.0 in 2023, then tumbled by 72.78% to $53865.0 in 2024, then tumbled by 52.5% to $25586.0 in 2025, then jumped by 1063.94% to $297806.0 in 2026.
- Per Business Quant, the three latest ODYY Cash & Current Investments figures stand at $297806.0 (Q2 2026), $616327.0 (Q1 2026), and $25586.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 297,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 297,806.00 |
| Jan 31, 2026 | 616,327.00 |
| Oct 31, 2025 | 25,586.00 |
| Jul 31, 2025 | 19,084.00 |
| Apr 30, 2025 | 3,186.00 |
| Jan 31, 2025 | 7,187.00 |
| Oct 31, 2024 | 53,865.00 |
| Jul 31, 2024 | 2,379.00 |
| Apr 30, 2024 | 66,014.00 |
| Jan 31, 2024 | 166,140.00 |
| Oct 31, 2023 | 197,882.00 |
| Jul 31, 2023 | 36,865.00 |
| Apr 30, 2023 | 1,234.00 |
| Jan 31, 2023 | 35,792.00 |
| Oct 31, 2022 | 50,499.00 |
| Jul 31, 2022 | 72,534.00 |
| Apr 30, 2022 | 266,300.00 |
| Jan 31, 2022 | 131,337.00 |
| Oct 31, 2021 | 471,140.00 |
| Jul 31, 2021 | 72,534.00 |